Featured
-
-
Article
| Open AccessExpression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies
- Ylenia Cicirò
- , Denise Ragusa
- & Arturo Sala
-
Article
| Open AccessRisk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
- Yuebing Chen
- , Chuying Chen
- & Cheng Lin
-
Article
| Open AccessAn inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer
- Mauricio Jacobo Jacobo
- , Hayley J. Donnella
- & Sourav Bandyopadhyay
-
Article
| Open AccessThe Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
- Mariam-Eleni Oraiopoulou
- , Eleftheria Tzamali
- & Vangelis Sakkalis
-
Article
| Open AccessA novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma
- Akinari Kasai
- , Jinsei Miyoshi
- & Tetsuji Takayama
-
Article
| Open AccessDevelopment of a claims-based risk-scoring model to predict emergency department visits in older patients receiving anti-neoplastic therapy
- Yewon Suh
- , Jonghyun Jeong
- & Ju-Yeun Lee
-
Article
| Open AccessEffectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary
- Harika Yumru Celiksoy
- , Catriona Dickie
- & Christina Fotopoulou
-
Article
| Open AccessPaclitaxel-induced inhibition of NSCLC invasion and migration via RBFOX3-mediated circIGF1R biogenesis
- Zhanyu Xu
- , Liping Zheng
- & Shikang Li
-
Article
| Open AccessDevelopment of a nomogram to predict survival in advanced biliary tract cancer
- Hiroshi Imaoka
- , Masafumi Ikeda
- & Makoto Ueno
-
Article
| Open AccessKinetic modelling of ultrasound-triggered chemotherapeutic drug release from the surface of gold nanoparticles
- Tyler K. Hornsby
- , Farshad Moradi Kashkooli
- & Jahangir (Jahan) Tavakkoli
-
Article
| Open AccessDetection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment
- Yoshitaka Saito
- , Shinya Tamaki
- & Mitsuru Sugawara
-
Article
| Open AccessSystematic review: predictive value of organoids in colorectal cancer
- B. Cristoffer Sakshaug
- , Evelina Folkesson
- & Åsmund Flobak
-
Article
| Open AccessRisk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients
- Yoshitaka Saito
- , Masaki Kobayashi
- & Mitsuru Sugawara
-
Article
| Open AccessTreatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
- Yuta Inoue
- , Takeshi Yamada
- & Osamu Ukimura
-
Article
| Open AccessImpact of fractionated cisplatin and radiation treatment on cell growth and accumulation of DNA damage in two normal cell types differing in origin
- Pamela Akuwudike
- , Milagrosa López-Riego
- & Andrzej Wojcik
-
Article
| Open AccessNon-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
- Jin-Ah Kim
- , Kenneth A. Crawford
- & Charles Keller
-
Article
| Open AccessEffect of the isotiazole adjuvants in combination with cisplatin in chemotherapy of neuroepithelial tumors: experimental results and modeling
- Vladimir Potkin
- , Aliaxandr Pushkarchuk
- & Vladimir A. Kulchitsky
-
Article
| Open AccessAllogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
- Paul Jäger
- , Christina Rautenberg
- & Guido Kobbe
-
Article
| Open AccessSurvival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
- Chihiro Sato
- , Hisato Kawakami
- & Kazuhiko Nakagawa
-
Article
| Open AccessCisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
- Thomas M. Steele
- , Maria Malvina Tsamouri
- & Paramita M. Ghosh
-
Article
| Open AccessPropensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer
- Yue Zhang
- , Shasha Fan
- & Jingjing Wang
-
Article
| Open AccessStreptozotocin induces renal proximal tubular injury through p53 signaling activation
- Kunihiro Nakai
- , Minato Umehara
- & Tetsuro Kusaba
-
Article
| Open AccessActivity of pemetrexed in pre-clinical chordoma models and humans
- Santosh Kesari
- , Feng Wang
- & Jaya M. Gill
-
Article
| Open AccessNEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells
- Umit Aliyaskarova
- , Yeldar Baiken
- & Regina Groisman
-
Article
| Open AccessThe cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
- Lenka Besse
- , Marianne Kraus
- & Ignazio Tarantino
-
Article
| Open AccessTemporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers
- Gina Hofmann
- , Jakob Zierk
- & Axel Karow
-
Article
| Open AccessThe interactions of monomeric acridines and unsymmetrical bisacridines (UAs) with DNA duplexes: an insight provided by NMR and MD studies
- Tomasz Laskowski
- , Michał Kosno
- & Zofia Mazerska
-
Article
| Open AccessPhase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer
- Takeshi Kato
- , Toshihiro Kudo
- & Hidetoshi Eguchi
-
Article
| Open AccessACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
- Dongwen Que
- , Feimei Kuang
- & Jiao Liu
-
Article
| Open AccessCharacterization of a novel dual murine model of chemotherapy-induced oral and intestinal mucositis
- Ali I. Mohammed
- , Antonio Celentano
- & Nicola Cirillo
-
Article
| Open AccessCT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients
- Simon Bernatz
- , Oleg Elenberger
- & Scherwin Mahmoudi
-
Article
| Open AccessMolecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer
- E. S. Grigoryeva
- , L. A.Tashireva
- & V. M. Perelmuter
-
Article
| Open AccessA randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
- Gabriel Lopez
- , Cathy Eng
- & Lorenzo Cohen
-
Article
| Open AccessSensing nitriles with THz spectroscopy of urine vapours from cancers patients subject to chemotherapy
- Vladimir Vaks
- , Vladimir Anfertev
- & Mauro Fernandes Pereira
-
Article
| Open AccessNetwork analysis to identify symptoms clusters and temporal interconnections in oncology patients
- Elaheh Kalantari
- , Samaneh Kouchaki
- & Payam Barnaghi
-
Article
| Open AccessCyclophilin A contributes to shikonin-induced glioma cell necroptosis and promotion of chromatinolysis
- Xinyu Wang
- , Liwen Fan
- & Linlin Liu
-
Article
| Open AccessPotentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
- Ruan F. V. Medrano
- , Thiago A. Salles
- & Bryan E. Strauss
-
Article
| Open AccessImproved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer
- Mu-Hung Tsai
- , Shang-Yin Wu
- & Yuan-Hua Wu
-
Article
| Open AccessNedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patients
- Chao Deng
- , Na Zhang
- & Tao Hou
-
Article
| Open AccessSingle-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model
- Tove Selvin
- , Erik Fasterius
- & Claes R. Andersson
-
Article
| Open AccessBexarotene-induced cell death in ovarian cancer cells through Caspase-4-gasdermin E mediated pyroptosis
- Tatsuya Kobayashi
- , Akira Mitsuhashi
- & Makio Shozu
-
Article
| Open AccessPonatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model
- Evan Flietner
- , Zhi Wen
- & Jing Zhang
-
Article
| Open AccessHOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma
- Toru Nakamura
- , Tsuyoshi Hayashi
- & Akinobu Taketomi
-
Article
| Open AccessCollateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse
- Simona Dalin
- , Beatrice Grauman-Boss
- & Michael T. Hemann
-
Article
| Open AccessA clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress
- Tom Egger
- , Benoît Bordignon
- & Arnaud Coquelle
-
Article
| Open AccessPD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
- Maria Davern
- , Rebecca M. O’ Brien
- & Joanne Lysaght
-
Article
| Open AccessOvarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene
- E. Ntemou
- , P. Diaz Vidal
- & I. Demeestere
-
Article
| Open AccessGastric cancer cell death analyzed by live cell imaging of spheroids
- George Alzeeb
- , Danielle Arzur
- & Catherine Le Jossic-Corcos
-
Article
| Open AccessA computational modeling approach for dosing endoscopic intratumoral chemotherapy for advanced non-small cell lung cancer
- Vitor Mori
- , Jason H. T. Bates
- & C. Matthew Kinsey